Author Agreement European Journal Of Pharmacology

Read more at:• Open access publication with Elsevier• Funding agreements• Open access licensing policy• Open access pricing policy For all research involving individuals, voluntary and informed consent to participate in the study must be obtained by participants (or their parents or legal guardians in the case of children under the age of 16) and a statement should be included in the manuscript. In the case of articles describing human transplantation studies, authors should add a statement explaining that no organs or tissues were obtained from prisoners and also mention the institution(s)/clinic(s)/department(s) through which organs/tissues were obtained. For manuscripts that report studies involving at-risk groups, for which consent may not be fully informed, the publisher will be particularly cautious and may be referred to the Springer Nature Research Integrity Group. Types of documents The journal publishes the following types of articles: 1. Research Paper 2. Summary articles These guidelines describe authoring principles and good authoring practices that potential authors should adhere to. Copyright When adopting an article, authors are invited to enter into a “Journal Publishing Agreement” (see more information on this subject). An e-mail is sent to the corresponding author, confirming receipt of the manuscript with a “Journal Publishing Agreement” form or a link to the online version of this agreement. Checklist for filing You can use this list to perform a final verification of your repository before sending it to the journal for verification.

Please read the corresponding section of this manual for more details. This journal is included in the JournalGuide-Whitelist of serious titles. Learn more here. The addition and/or removal of authors during the revision phase is generally not allowed, but may be justified in some cases. The reasons for these changes in the author should be explained. Approval of the amendment during the revision is at the discretion of the Editor-in-Chief. Please note that magazines may have individual guidelines on adding and/or removing authors during the review period. In the absence of specific instructions and in areas of research where it is possible to describe discrete efforts, the publishing house recommends that authors include in the book statements of contribution that specify the contribution of each author to promote transparency. These contributions should appear on the separate cover page. It is difficult to set a threshold where a financial interest becomes significant, such a figure is necessarily arbitrary, so a possible practical guideline is as follows: “Any undeclared financial interest that could embarrass the author if it were made public after the publication of the work.” For gold open access articles: after the adoption of an article, authors are invited to enter into an “exclusive license agreement” (more information).

. . .